Werewolf Therapeutics (HOWL) Assets (2020 - 2026)
Werewolf Therapeutics (HOWL) posted quarterly Assets of $24.2 million for Q2 2026, down 73.91% year-over-year from $92.6 million in Q2 2025, and down 58.37% on a QoQ basis from $58.0 million in Q1 2026.
Werewolf Therapeutics (HOWL) Assets (2020 - 2026) Analysis & Trends
Werewolf Therapeutics has reported Assets for 7 years, with the latest figure at $24.2 million in Q2 2026.
- Assets for Q2 2026 came in at $24.2 million, down 73.91% year-over-year; the trailing twelve-month figure through Jun 2026 was $24.2 million (down 73.91% YoY), and the FY2025 annual result was $69.4 million, down 45.33% from the prior year.
- Assets declined to $24.2 million in Q2 2026, from $58.0 million in the prior quarter.
- Over five years, Assets peaked at $195.1 million in Q1 2023 and troughed at $24.2 million in Q2 2026.
- A 5-year average of $135.2 million and a median of $157.0 million in 2022 frame the typical range for Assets.
- The widest annual swing landed in 2022, when Assets soared 84.08%; it then sank 73.91% in 2026.
- A 5-year view of Assets shows it stood at $160.2 million in 2022, then increased by 9.1% to $174.8 million in 2023, then declined by 27.4% to $126.9 million in 2024, then plunged by 45.33% to $69.4 million in 2025, then sank by 65.19% to $24.2 million in 2026.
- Per Business Quant data, the three most recent Assets figures were $24.2 million in Q2 2026, $58.0 million in Q1 2026, and $69.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.57 Bn | 130.72 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 77.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 65.00 Bn | 59.82 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 56.27 Bn | 51.13 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.00 Bn | 36.90 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 27.68 Bn | 9.29 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.43 Bn | 26.27 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.34 Bn | 26.51 Bn | - | 19.82 Bn |
| 10 | Werewolf Therapeutics | 42.97 Mn | 42.97 Mn | - | 24.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.16 Mn |
| Mar 31, 2026 | 58.02 Mn |
| Dec 31, 2025 | 69.40 Mn |
| Sep 30, 2025 | 79.63 Mn |
| Jun 30, 2025 | 92.57 Mn |
| Mar 31, 2025 | 107.24 Mn |
| Dec 31, 2024 | 126.93 Mn |
| Sep 30, 2024 | 140.04 Mn |
| Jun 30, 2024 | 153.70 Mn |
| Mar 31, 2024 | 177.60 Mn |
| Dec 31, 2023 | 174.83 Mn |
| Sep 30, 2023 | 176.39 Mn |
| Jun 30, 2023 | 185.24 Mn |
| Mar 31, 2023 | 195.07 Mn |
| Dec 31, 2022 | 160.25 Mn |
| Sep 30, 2022 | 172.42 Mn |
| Jun 30, 2022 | 175.33 Mn |
| Mar 31, 2022 | 164.63 Mn |
| Dec 31, 2021 | 179.25 Mn |
| Sep 30, 2021 | 178.38 Mn |